GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medy-Tox Inc (XKRX:086900) » Definitions » Shiller PE Ratio

Medy-Tox (XKRX:086900) Shiller PE Ratio : 18.11 (As of May. 15, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Medy-Tox Shiller PE Ratio?

As of today (2024-05-15), Medy-Tox's current share price is ₩135500.00. Medy-Tox's E10 for the quarter that ended in Dec. 2023 was ₩7,481.07. Medy-Tox's Shiller PE Ratio for today is 18.11.

The historical rank and industry rank for Medy-Tox's Shiller PE Ratio or its related term are showing as below:

XKRX:086900' s Shiller PE Ratio Range Over the Past 10 Years
Min: 13.28   Med: 29.4   Max: 132.94
Current: 18.11

During the past years, Medy-Tox's highest Shiller PE Ratio was 132.94. The lowest was 13.28. And the median was 29.40.

XKRX:086900's Shiller PE Ratio is ranked better than
76.82% of 151 companies
in the Biotechnology industry
Industry Median: 35.74 vs XKRX:086900: 18.11

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Medy-Tox's adjusted earnings per share data for the three months ended in Dec. 2023 was ₩-309.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ₩7,481.07 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Medy-Tox Shiller PE Ratio Historical Data

The historical data trend for Medy-Tox's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medy-Tox Shiller PE Ratio Chart

Medy-Tox Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 45.26 31.02 20.36 17.36 32.21

Medy-Tox Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.36 29.59 31.08 33.20 32.21

Competitive Comparison of Medy-Tox's Shiller PE Ratio

For the Biotechnology subindustry, Medy-Tox's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medy-Tox's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medy-Tox's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Medy-Tox's Shiller PE Ratio falls into.



Medy-Tox Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Medy-Tox's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=135500.00/7481.07
=18.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medy-Tox's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Medy-Tox's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-309/118.8477*118.8477
=-309.000

Current CPI (Dec. 2023) = 118.8477.

Medy-Tox Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 987.685 99.253 1,182.675
201406 1,303.610 99.353 1,559.400
201409 3,316.440 99.608 3,957.024
201412 1,008.040 99.098 1,208.937
201503 1,302.800 99.720 1,552.695
201506 1,796.230 100.050 2,133.711
201509 1,600.000 100.110 1,899.474
201512 1,753.890 100.220 2,079.882
201603 2,080.410 100.560 2,458.750
201606 2,437.860 100.790 2,874.631
201609 2,234.300 101.460 2,617.203
201612 2,311.660 101.560 2,705.154
201703 2,608.040 102.850 3,013.705
201706 3,160.100 102.610 3,660.176
201709 2,046.210 103.490 2,349.863
201712 2,982.600 102.990 3,441.840
201803 3,335.980 104.100 3,808.584
201806 2,770.080 104.130 3,161.602
201809 2,222.090 105.650 2,499.671
201812 2,842.950 104.350 3,237.931
201903 2,101.730 104.490 2,390.523
201906 1,622.840 104.880 1,838.966
201909 478.885 105.200 541.011
201912 -33.631 105.120 -38.023
202003 -919.123 105.540 -1,035.017
202006 -918.259 104.870 -1,040.650
202009 -8.638 106.200 -9.667
202012 -2,994.800 105.765 -3,365.232
202103 8,629.480 107.357 9,553.098
202106 4,848.070 107.579 5,355.916
202109 3,226.300 108.759 3,525.571
202112 -1,502.720 109.676 -1,628.380
202203 639.048 111.806 679.297
202206 3,020.000 114.083 3,146.136
202209 2,098.100 114.831 2,171.484
202212 -19.714 115.200 -20.338
202303 699.000 116.550 712.783
202306 1,273.000 117.140 1,291.559
202309 -353.000 119.111 -352.219
202312 -309.000 118.848 -309.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Medy-Tox  (XKRX:086900) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Medy-Tox Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Medy-Tox's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Medy-Tox (XKRX:086900) Business Description

Traded in Other Exchanges
N/A
Address
641-4, Gak-Ri, Ochang-Eup, Cheongwon, KOR, 363885
Medy-Tox Inc. is a Korea-based company engaged in the development, manufacture, and marketing of biopharmaceuticals. The company's main product is type-A botulium toxin biopharmaceuticals which are used as remedies for blepharospasms, hemifacial spasms, eye wrinkles, hyperhidrosis diseases and infantile cerebral palsy. The group provides its products under the brand names of Neuronox, Siax and others. It distributes its products within Korean and to overseas markets, such as Japan, China, Russia and Europe, among others.

Medy-Tox (XKRX:086900) Headlines

No Headlines